Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model.
Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model.
复制标题
与海马过度活跃有关的可逆性 GABA 功能障碍可预测小鼠模型中的早期阿尔茨海默病。
DOI:
10.1186/s13195-021-00859-8
复制
发表时间:
2021-06-14
期刊:
影响因子:
--
通讯作者:
Zheng Y
中科院分区:
文献类型:
--
作者:
Li Y;Zhu K;Li N;Wang X;Xiao X;Li L;Li L;He Y;Zhang J;Wo J;Cui Y;Huang H;Zhang J;Wang W;Wang X;Zheng Y
Neuronal hyperactivity related to β-amyloid (Aβ) is considered an early warning sign of Alzheimer disease (AD). Although increasing evidence supports this opinion, the underlying mechanisms are still unknown. Here, we recorded whole-cell synaptic currents and membrane potentials using patch clamping of acute hippocampal slices from human amyloid precursor protein (APP)/presenilin-1 transgenic (5XFAD) mice and their wild-type littermates. Biochemical methods, electron microscopic imaging, behavioral tests, and intraventricular drug delivery applied with osmotic pumps were used in this study. We confirmed hyperactivity of hippocampal CA1 pyramidal neurons in 5XFAD mice using whole-cell electrophysiological recording at 2.5 months old, when local Aβ-positive plaques had not developed and only mild cognitive dysfunction occurred. We further discovered attenuated inhibitory postsynaptic currents and unchanged excitatory postsynaptic currents in CA1 pyramidal neurons, in which the intrinsic excitability was unchanged. Moreover, the density of both γ-aminobutyric acid A (GABAA) receptor subunits, α1 and γ2, was reduced in synapses of the hippocampus in transgenic mice. Intriguingly, early intervention with the GABAA receptor agonist gaboxadol reversed the hippocampal hyperactivity and modestly ameliorated cognitive performance in 5XFAD mice under our experimental conditions. Inhibitory postsynaptic disruption critically contributes to abnormalities in the hippocampal network and cognition in 5XFAD mice and possibly in AD. Therefore, strengthening the GABAergic system could be a promising therapy for AD in the early stages. The online version contains supplementary material available at 10.1186/s13195-021-00859-8.
登录
查看更多内容
DOI:
10.1196/annals.1379.003
发表时间:
2007-01-01
期刊:
IMAGING AND THE AGING BRAIN
影响因子:
--
作者:
Grutzendler, Jaime;Helmin, Kathryn;Gan, Wen-Biao
通讯作者:
Gan, Wen-Biao
影响因子:
25
作者:
Palop, Jorge J.;Mucke, Lennart
通讯作者:
Mucke, Lennart
DOI:
10.1073/pnas.1206171109
发表时间:
2012-05-29
影响因子:
11.1
作者:
Busche, Marc Aurel;Chen, Xiaowei;Konnerth, Arthur
通讯作者:
Konnerth, Arthur
影响因子:
16.6
作者:
Dinamarca, Margarita C.;Raveh, Adi;Bettler, Bernhard
通讯作者:
Bettler, Bernhard
影响因子:
56.9
作者:
Sando, Richard;Jiang, Xian;Sudhof, Thomas C.
通讯作者:
Sudhof, Thomas C.